Introduction {#S0001}
============

Febrile seizure (FS) as the most common form of seizures in childhood, affects 2-5% of all children across the world^\[[@CIT0001],\ [@CIT0002]\]^. Children rarely develop their first FS before the age of 6 months or after 3 years of age\[[@CIT0003]\]. The International League Against Epilepsy has defined that seizure events in infancy or childhood is featured with temperatures over 38° C without evidence of acute electrolyte imbalances and CNS infection or history of FS^\[[@CIT0004]\]^.

The direct cause of FS is unknown yet, but the most important indirect causes are reported to be fever, hypoglycemia, hypocalcemia, head injury, poisoning and drug overuse, respiratory infection or gastroenteritis^\[[@CIT0005]\]^.

There are two categories of FS including simple and complex types^\[[@CIT0006]\]^. The simple type is characterized by an episode of generalized tonic-clonic seizure lasting less than 15 min in 24 h while in the complex type the convulsions are multiple, lasting more than 15 min. Majority (70%-75%) of FSs are of simple type^\[[@CIT0006],\ [@CIT0007]\]^.

A positive family history for FS can be elicited in 25-40% of the patients^\[[@CIT0008]\]^. A high concordance rate has been reported in monozygotic rather in dizygotic twins^\[[@CIT0008],\ [@CIT0009]\]^. The overall recurrence rate is 30%^\[[@CIT0010]\]^. Predictors of recurrence are complex seizures, positive family history, onset at less than 12 months and temperature \<40°C. If the seizure occurs soon after a fever has begun or when the temperature is relatively low, the risk of recurrence will be increased^\[[@CIT0011]\]^. A long initial FS does not substantially boost the risk of recurrent FS, either brief or long^\[[@CIT0012]\]^. The odds that children develop epilepsy after a FS is approximately 1%^\[[@CIT0013]\]^.

Since a systematic review and meta-analysis on FS recurrence in Iran has not yet been done, the present study reviews available reports on FS recurrence frequency and evaluates its associated risk factors in this country.

Subjects and Methods {#S0002}
====================

Literature search {#S20003}
-----------------

The search strategy, selection of publications and the reporting of results for the review was conducted in accordance with the PRISMA guidelines^\[[@CIT0014]\]^. Literature on FS among Iranian children was acquired through searching Scientific Information Databases (SID), Global Medical Article Limberly (Medlib), Iranian Biomedical Journal (Iran Medex), Iranian Journal Database (Magiran) as well as international databases including PubMed/Medline, Scopus and ISI Web of Knowledge. The search strategy was limited to the Persian and/or English language and articles published up until Feb 2012 were considered. All publications with medical subject headings (MeSh) and keywords in title, abstract and text for words including febrile seizure were investigated. Iranian scientific databases were searched only using the keyword 'febrile seizure', as these databases do not distinguish synonyms from each other and do not allow sensitive search operation using linking terms such as 'AND', 'OR' or 'NOT'. Consequently, this single keyword search was the most practical option. The seizures, pediatrics and Iran MeSh combined with the operator "OR" vs. "AND". The search string in PubMed was ((Seizures \[Title\]) OR Pediatrics \[Title\]) AND Iran \[Affiliation\]).

Selection and quality assessment of articles {#S20004}
--------------------------------------------

All identified papers were critically appraised independently by two reviewers. Disagreements between reviewers were resolved by consensus. Appraisal was guided by a checklist assessing clarity of aims and research questions. The inclusion criteria were as follow: 1) Studies in the mentioned databases with full text, despite the language of original text; 2) Hospital-based data. Exclusion criteria were 1) studies upon children overlapping time intervals of sample collection from the same origin; 2) inappropriate study design; 3) Inadequate reporting of results; 4) STROBE checklist score\'s below 7.75^\[[@CIT0015]\]^.

Data extraction {#S20005}
---------------

Data were extracted using a standardized and pre-piloted data extraction form. Data extraction was undertaken by the first reviewer and checked by a second reviewer. However, the process was discussed and piloted by both reviewers. All identified papers were critically appraised independently by both reviewers. Disagreements were resolved through discussion. Appraisal was guided by a checklist assessing clarity of aims and research questions. Information was extracted from author, title, year and setting of study, sample selection, sample size, study type, seizure types, age, STROBE score and prevalence. Therefore risk of bias as an inadequate reporting was reduced. All data-abstraction forms were reviewed and eligible papers entered into the meta-analysis.

Statistical analysis {#S20006}
--------------------

The random effects model was used for combining results of studies in meta-analysis. Variance for each study was calculated using the binomial distribution formula. The presence of heterogeneity was determined by the Der Simonian-Laird (DL) approach^\[[@CIT0016]\]^. Significance level was \<0.1 and I^2^ statistic for estimates of inconsistency within the meta-analyses. The I^2^ statistic estimates the percent of observed between-study variability due to heterogeneity rather than to chance and ranges from 0 to 100 percent (values of 25%, 50% and 75% were considered representing low, medium and high heterogeneity respectively)^\[[@CIT0017]\]^. A value of 0% indicates no observed heterogeneity whilst 100% indicates significant heterogeneity. For this review we determined that I^2^ values above 75 percent were indicative of significant heterogeneity warranting analysis with a random effect model as opposed to the fixed effect model to adjust for the observed variability. This heterogeneity was further explored through subgroup analyses and meta-regression. A univariate and multivariate approach was employed to assess the causes of heterogeneity among the selected studies. Egger test was conducted to examine potential publication bias. Data manipulation and statistical analyses were done using STATA software, version 11.2. *P* values \<0.05 were considered as statistically significant.

Findings {#S0007}
========

Overall, 96 studies (1 study in Pub Med, 95 studies in other databases) were identified. Of them, 75 studies were excluded based on the inclusion and exclusion criteria. Finally 21 articles including 1 in English^\[[@CIT0018]\]^ and 20 in Persian^\[[@CIT0019]--[@CIT0038]\]^ language were adopted ([Fig. 1](#F0001){ref-type="fig"}). Looking for sample sizes, throughout the 21 selected studies, 4599 FS children (219 samples per study on average) including 2734 males (59.5%) were studied ([Table 1](#T0001){ref-type="table"}). Age distribution and type of FSs prevalence in children under two years and 3 to 6 years were 55.8% (95%CI: 50.4--61.2) and 44.1% (95%CI: 38.8-62.2), respectively. Prevalence of simple and complex FS was 69.3% (95%CI: 59.5-79.0) and 28.3% (95%CI: 19.6-31.0), respectively ([Table 2](#T0002){ref-type="table"}). Significant hetero-geneity was observed between studies (Q = 75.24, *P*≤0.001, I^2^=92.0%) and consequently the random effect model was employed for the meta-analysis. Recurrence and positive familial history of FS was observed in 28.8 children (95%CI: 19.3-38.4) ([Fig. 2A](#F0002){ref-type="fig"}).

![Results of the systematic literature search](IJPD-23-389-g001){#F0001}
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###### 

Feature of childhood febrile seizure at different regions of Iran

  Study location (city)   First author (year)                      Study period   No. of patients   Gender (male) n (%)   Data collection procedure   Quality[\*](#TF0001){ref-type="table-fn"}
  ----------------------- ---------------------------------------- -------------- ----------------- --------------------- --------------------------- -------------------------------------------
  Bandar Abbas            Ahmadian (1996) ^\[[@CIT0019]\]^         1996-1997      211               127 (0.60)            Hospital                    High
  Isfahan                 Amini (2008) ^\[[@CIT0020]\]^            2005-2007      1486              892 (0.60)            Hospital                    High
  Mashhad                 Ashrafzadeh (2002) ^\[[@CIT0021]\]^      2001-2002      50                35 (0.70)             Hospital                    High
  Tabriz                  Barzegar (2006) ^\[[@CIT0022]\]^         2001-2003      582               321 (0.55)            Hospital                    High
  Ahvaz                   Dehdashtian (2008) ^\[[@CIT0023]\]^      2003-2008      94                54 (0.57)             Hospital                    High
  Tehran                  Ehsanypoor (2004) ^\[[@CIT0024]\]^       1997-2007      245               140 (0.57)            Hospital                    Medium
  Yazd                    Fallah (2008) ^\[[@CIT0025]\]^           2004-2005      139               63 (0.55)             Hospital                    High
  Sanandaj                Ghotbi (2002) ^\[[@CIT0026]\]^           2000-2001      115               70 (0.61)             Hospital                    Medium
  Yazd                    Golestan (2008) ^\[[@CIT0027]\]^         2002-2005      100               59 (0.59)             Hospital                    High
  Tehran                  Hassanpoor (2009) ^\[[@CIT0028]\]^       2003-2005      103               64 (0.62)             Hospital                    High
  Kerman                  Hosseininasab (2006) ^\[[@CIT0029]\]^    2000-2002      115               68 (0.59)             Hospital                    High
  Zanjan                  Kazemi (2001) ^\[[@CIT0030]\]^           2000-2001      50                33 (0.66)             Hospital                    High
  Zahedan                 Khazai (2007) ^\[[@CIT0031]\]^           2005-2006      178               94 (0.53)             Hospital                    High
  Tehran                  Khodapanahandeh (2001)^\[[@CIT0032]\]^   2007-2008      107               64.60)                Hospital                    High
  Bandar Abbas            Moayedi (2001) ^\[[@CIT0033]\]^          2001-2002      181               112 (0.62)            Hospital                    Medium
  Ilam                    Mohammadi (2008) ^\[[@CIT0034]\]^        2007-2008      172               98 (0.57)             Hospital                    High
  Birjand                 Namakin (2011) ^\[[@CIT0035]\]^          2006-2007      145               84 (0.61)             Hospital                    High
  Babel                   Rasholi (1999) ^\[[@CIT0036]\]^          1999-2000      230               138 (0.60)            Hospital                    High
  Zanjan                  Sadeghzadeh (2011) ^\[[@CIT0037]\]^      2005-2006      117               64 (0.55)             Hospital                    High
  Bushehr                 Sanaidashti (2006) ^\[[@CIT0038]\]^      2005-2006      102               64 (0.65)             Hospital                    Low
  Kashan                  Talebian (2006) ^\[[@CIT0042]\]^         2001-2002      120               72 (0.60)             Hospital                    Medium

Score of STROBE checklist. Under 7.75 = excluded; among 7.75 to 15.5: low; among 15.5 to 23.5: medium; higher than 23.5: High

###### 

Prevalence of febrile seizure among Iranian children through random effect models

  Variables                 No. of studies   No. of Patients   Prevalence% (95% CI)   Heterogeneity   
  ------------------------- ---------------- ----------------- ---------------------- --------------- ---------
  **Simple seizures**       13               1859              69.3(59.5-79.0)        96.5            \<0.001
  **complex seizures**      12               1809              25.3(19.6-31.0)        88.8            \<0.001
  **Less than two years**   9                1587              55.8(50.4-61.2)        77.0            \<0.001
  **Tree to six years**     9                1456              44.2(38.8-49.6)        77.0            \<0.001

CI: Confidence Interval

Overall recurrence rate of FS was 20.9 percent with (95%CI: 12.3-29.5) ([Fig. 2B](#F0002){ref-type="fig"}). Meta-regression showed association between year of study and prevalence rate of recurrent FS, it showed also causes of the variability in the results of studies. Meta-regression showed variability in prevalence of recurrent FS a non-significant effect for years (Reg Coef = 0.017, *P*=0.1). [Fig. 3](#F0003){ref-type="fig"} shows the prevalence rate of recurrent FS that has had an increasing trend during 1995 till 2010. Meta-regression analysis found that sample size significantly affects heterogeneity for the factor 'recurrent rate FS' (Reg Coef =0.0003, *P*=0.03) ([Fig. 3](#F0003){ref-type="fig"}). Meta-regression showed that one reason of variability among studies is sample size; studies with large sample size show higher prevalence rate of recurrent FS in comparison to studies with small sample size. Publication bias is a bias with regard to what is likely to be published, among what is available to be published. Publication bias is the term for what occurs whenever the research that appears in the published literature is systematically unrepresentative of the population of completed studies. There was no evidence of publication bias (Egger\'s test β0: 0.04; *P*=0.96) ([Fig. 4](#F0004){ref-type="fig"}), so we tried to consider most of published articles in this subject.

![Meta-regression plots of change in FS recurrence according to changes in continuous study moderator\'s year and sample size](IJPD-23-389-g003){#F0003}
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Discussion {#S0008}
==========

The present review aimed to provide recurrent rate and predictive risk factors that enhance risk of recurrence in Iranian children using the Persian and/or English language articles published up to Feb 2012. This study shows that the pool recurrence FS among Iranian children was (20.9%). Previous review studies have reported (Berg, 1990; Offringa, 1994) this as being 31.8% and 32%, respectively^\[[@CIT0002],\ [@CIT0010]\]^. Berg (2008) has reported recurrence rate of 40-50% in untreated children^\[[@CIT0039]\]^. A possible explanation for this inconsistency might be due to the fact that our result was hospital-based and patients were treated. Therefore, treatment process may reduce this risk. Meta-regression thus helps exploring several possible reasons for the observed heterogeneity among studies. Results of the meta-regression found no statistically significant relation between year variations in recurrence of FS which shows an approximately constant recurrence during study period. Results of the meta-regression also found that recurrence of FS and sample size produced significant levels of heterogeneity. As a result, increasing the sample size is associated with increased recurrence ([Fig. 4](#F0004){ref-type="fig"}). Younger age at onset is important predictor of recurrent FSs and also increases the risk of later FS^\[[@CIT0043]\]^. Peak of FS episode lies in the first year of life. Thereafter incidence declines with increasing age^\[[@CIT0003]\]^. 58.8% of children with FS were younger than 24 months in this study. These findings correlate with study conducted by Shi XL et al instudy 2012, Most (75.7%) children experienced their first onset of FS at 6 months to 3 years of age (median: 16 months), 39.5% of cases were below 12 months and 60.50% over 12 months^\[[@CIT0040]\]^.

A positive family history of FS reveals the importance of genetic factors and common environmental exposures^\[[@CIT0009]\]^. Berg (2008) found that family history was not consistently associated with an increased risk of FS^\[[@CIT0039]\]^. In the present study, 28.8% of children had a positive family history of FS in agreement with Eseigbe (2012) findings which showed a prevalence rate of 29.4%^\[[@CIT0008]\]^. Tosune (2011) reported that 57% of children with FS had a positive family history^\[[@CIT0041]\]^. Other studies have also reported similar results confirming that positive family history increases risk of FS significantly^\[[@CIT0002],\ [@CIT0040],\ [@CIT0041]\]^. The positive family history for the simple and complex type was 36.2% and 29.4%, respectively which is consistent with other reports^\[[@CIT0006]\]^.

There are some limitations in the present study which need to be addressed. It was an observational study and patients were not randomly selected. Therefore selection bias and confounding seem to be expected. Meanwhile, the authors' ability to assess the quality of studies was limited by the fact that many studies failed to offer detailed information of selected subjects or valid data on important factors.

Conclusion {#S0009}
==========

Our analysis suggests the need for large population-based incidence studies of febrile seizure, particularly in children aged under six year, to generate more accurate estimates as well as provide a reasonably robust assessment of heterogeneity. Almost one-third of FS children had a positive familial history. The increased risk of recurrence in patients with symptomatic seizures needs to be fully considered by parents, physicians, nurses and health policy makers.
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